With fewer than 1 in 4 patients with cirrhosis surveilled for HCC, the American Gastroenterological Association (AGA) has ...

Non-contrast MRI as a surveillance tool for recurrent hepatocellular carcinoma after curative treatment: A prospective multicenter intra-individual comparison trial. First line atezolizumab + ...

Patients who are not eligible for surgical resection may or may not be eligible for liver transplant, depending on the extent of their disease, as outlined by the Milan and other criteria above. Some ...

A novel molecular imaging agent targeting glypican-3 (GPC3) has demonstrated high sensitivity and specificity in detecting hepatocellular carcinoma (HCC), including tumors smaller than one centimeter, ...

Recent advances in CT, MRI, ultrasound, and AI are transforming liver disease diagnosis, enabling earlier, more accurate, and less invasive detection of conditions like fibrosis, steatosis, and ...

A multi-omics blood assay, HCCscreen, demonstrated superior performance for detecting hepatocellular carcinoma (HCC) in patients with hepatic cirrhosis compared with individual bi ...

Radiology for liver and biliary diseases is evolving by combining decades of classic imaging expertise with advanced AI tools and emerging microbiome research. From identifying hallmark signs on CT ...

Please provide your email address to receive an email when new articles are posted on . This month’s cover story highlights the growing burden of hepatocellular carcinoma, the most common type of ...

According to the Centers for Disease Control and Prevention (CDC), approximately 25,000 men and 11,000 women are diagnosed with liver cancer each year. Early detection and treatment are key to ...